A Study to Continue the Administration of Deucravacitinib in Participants With Systemic Lupus Erythematosus (SLE) or Discoid and/or Subacute Cutaneous Lupus Erythematosus (DLE/SCLE) Who Have Completed Study IM011074 or Study IM011132

Clinical trial NCT06875960 · RECRUITING

Trial details

NCT number: NCT06875960
Sponsor: Bristol-Myers Squibb
Status: RECRUITING
Phase: Phase 4
Study type: INTERVENTIONAL

Systemic Lupus Erythematosus (SLE)Discoid and/or Subacute Cutaneous Lupus Erythematosus (DLE/SCLE)

Start date: 2026-02-24
Primary completion: 2026-12-01
Enrollment: 35

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.